- Home
- ELUT vs EPM Comparison
ELUT vs EPM Comparison
Compare ELUT & EPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELUT
- EPM
- Stock Information
- Founded
- ELUT 2015
- EPM 2003
- Country
- ELUT United States
- EPM United States
- Employees
- ELUT N/A
- EPM N/A
- Industry
- ELUT Medical Specialities
- EPM Oil & Gas Production
- Sector
- ELUT Health Care
- EPM Energy
- Exchange
- ELUT Nasdaq
- EPM Nasdaq
- Market Cap
- ELUT 94.0M
- EPM N/A
- IPO Year
- ELUT 2020
- EPM 1996
- Fundamental
- Price
- ELUT $1.99
- EPM $4.20
- Analyst Decision
- ELUT Strong Buy
- EPM Buy
- Analyst Count
- ELUT 2
- EPM 1
- Target Price
- ELUT $9.00
- EPM $6.50
- AVG Volume (30 Days)
- ELUT 40.2K
- EPM 149.7K
- Earning Date
- ELUT 05-08-2025
- EPM 05-13-2025
- Dividend Yield
- ELUT N/A
- EPM 11.59%
- EPS Growth
- ELUT N/A
- EPM N/A
- EPS
- ELUT N/A
- EPM 0.04
- Revenue
- ELUT $24,375,000.00
- EPM $86,423,000.00
- Revenue This Year
- ELUT $39.35
- EPM $4.28
- Revenue Next Year
- ELUT $61.26
- EPM $8.45
- P/E Ratio
- ELUT N/A
- EPM $99.15
- Revenue Growth
- ELUT N/A
- EPM N/A
- 52 Week Low
- ELUT $1.79
- EPM $4.08
- 52 Week High
- ELUT $5.24
- EPM $6.14
- Technical
- Relative Strength Index (RSI)
- ELUT 39.97
- EPM 40.98
- Support Level
- ELUT $1.79
- EPM $4.05
- Resistance Level
- ELUT $2.07
- EPM $4.21
- Average True Range (ATR)
- ELUT 0.20
- EPM 0.11
- MACD
- ELUT -0.00
- EPM 0.02
- Stochastic Oscillator
- ELUT 33.08
- EPM 40.30
About ELUT Elutia Inc.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.